VASP
Vasodilator-stimulated phosphoprotein
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
kinase | 0.97 | ||
biological term | 0.91 | ||
transcription factor | 0.91 | ||
transcription factor binding site profile | 0.86 | ||
cellular component | 0.82 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Adaptive Immune System | ||||
Reactome | Axon guidance | ||||
Reactome | Cell junction organization | ||||
Reactome | Cell-Cell communication | ||||
Reactome | Cell-extracellular matrix interactions | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Adaptive Immune System | ||||
Axon guidance | ||||
Cell junction organization | ||||
Cell-Cell communication | ||||
Cell-extracellular matrix interactions | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Inferred from Physical Interaction (IPI) | UniProtKB | |||
Inferred from High Throughput Direct Assay (HDA) | BHF-UCL | |||
Inferred from Electronic Annotation (IEA) | UniProtKB-KW | |||
Inferred from Electronic Annotation (IEA) | UniProtKB-KW | |||
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
heel bone mineral density | 3 | 4 | 6 | 91.1 | |||||
apolipoprotein B measurement | 1 | 3 | 3 | 84.3 | |||||
C-reactive protein measurement | 2 | 3 | 3 | 71.8 | |||||
low density lipoprotein cholesterol measurement | 1 | 2 | 2 | 68 | |||||
total cholesterol measurement | 1 | 1 | 1 | 12.2 | |||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
heel bone mineral density | 6 | 91.1 | |||||
apolipoprotein B measurement | 3 | 84.3 | |||||
C-reactive protein measurement | 3 | 71.8 | |||||
low density lipoprotein cholesterol measurement | 2 | 68 | |||||
total cholesterol measurement | 1 | 12.2 | |||||
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Macaque | vasodilator stimulated phosphoprotein | 716022 | ||||||
Mouse | MGI:109268 | 22323 | ||||||
Rat | RGD:1311542 | 361517 | ||||||
Dog | vasodilator stimulated phosphoprotein | 403936 | ||||||
Horse | vasodilator stimulated phosphoprotein | VGNC:24885 | 100070851 | |||||
Species | Name | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|
Macaque | vasodilator stimulated phosphoprotein | |||||
Mouse | ||||||
Rat | ||||||
Dog | vasodilator stimulated phosphoprotein | |||||
Horse | vasodilator stimulated phosphoprotein | |||||
PMID | Year | Title |
---|